Overview
Boomerang dysplasia is an extremely rare and lethal skeletal disorder (osteochondrodysplasia) characterized by severe dwarfism and distinctive skeletal abnormalities that are apparent prenatally or at birth. The name derives from the characteristic boomerang-shaped appearance of the long bones, particularly the femora, seen on radiographic imaging. This condition is caused by heterozygous mutations in the FLNB gene (filamin B), which plays a critical role in skeletal development and cartilage formation. Boomerang dysplasia is considered the most severe condition within the spectrum of FLNB-related skeletal disorders, which also includes atelosteogenesis types I and III and Larsen syndrome. The disease profoundly affects the skeletal system, with key features including severe limb shortening (micromelia), underossification (reduced mineralization) of the vertebral bodies and limb bones, absent or severely hypoplastic long bones with the characteristic boomerang shape, encephalocele (protrusion of brain tissue through the skull), and distinctive facial features including a flat midface, widely spaced eyes (hypertelorism), and a depressed nasal bridge. Additional findings may include omphalocele, finger and nail abnormalities, and dislocated joints. The thorax is often narrow and underdeveloped. Boomerang dysplasia is uniformly lethal, with affected individuals typically dying in utero or in the early neonatal period due to respiratory insufficiency related to the severely underdeveloped thorax and lungs. There is no curative treatment available. Management is limited to supportive and palliative care. Prenatal diagnosis may be possible through ultrasound identification of the characteristic skeletal abnormalities and can be confirmed by molecular genetic testing of the FLNB gene. Genetic counseling is recommended for affected families.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Boomerang dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Boomerang dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Boomerang dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Boomerang dysplasia.
Community
No community posts yet. Be the first to share your experience with Boomerang dysplasia.
Start the conversation →Latest news about Boomerang dysplasia
No recent news articles for Boomerang dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Boomerang dysplasia
What is Boomerang dysplasia?
Boomerang dysplasia is an extremely rare and lethal skeletal disorder (osteochondrodysplasia) characterized by severe dwarfism and distinctive skeletal abnormalities that are apparent prenatally or at birth. The name derives from the characteristic boomerang-shaped appearance of the long bones, particularly the femora, seen on radiographic imaging. This condition is caused by heterozygous mutations in the FLNB gene (filamin B), which plays a critical role in skeletal development and cartilage formation. Boomerang dysplasia is considered the most severe condition within the spectrum of FLNB-rel
How is Boomerang dysplasia inherited?
Boomerang dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Boomerang dysplasia typically begin?
Typical onset of Boomerang dysplasia is neonatal. Age of onset can vary across affected individuals.